WAM
BBIO icon

Weiss Asset Management’s BridgeBio Pharma BBIO Stock Holding History

Weiss Asset Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8M Buy
+320,184
New +$22.4M 0.25% 71
2026
Q1 		– Sell
-8,613
Closed -$659K – 532
2025
Q4 		$659K Buy
+8,613
New +$565K 0.01% 451
2025
Q2 		– Sell
-1
Closed -$35 – 421
2025
Q1 		$35 Buy
+1
New +$34 ﹤0.01% 304
2020
Q2 		– Sell
-161,500
Closed -$4.68M – 199
2020
Q1 		$4.68M Buy
+161,500
New +$5.01M 0.75% 23

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Weiss Asset Management's BBIO Position: Q2 2026 in Review

Weiss Asset Management opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 320,184 shares worth $23.8M. The stake represents 0.25% of the portfolio and ranks #71 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in BBIO as recently as Q4 2025.

Weiss Asset Management first reported a position in BBIO in Q1 2020 and has held it in 4 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Weiss Asset Management held 320,184 shares of BridgeBio Pharma worth $23.8M as of Q2 2026.
  • BridgeBio Pharma was a new Weiss Asset Management position in Q2 2026.
  • BridgeBio Pharma made up 0.25% of Weiss Asset Management's portfolio in Q2 2026, its #71 holding.
  • Weiss Asset Management first reported a position in BridgeBio Pharma in Q1 2020 and has held it in 4 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.